Literature DB >> 3235678

Comparison of sensitivities and specificities of latex agglutination and an enzyme-linked immunosorbent assay for detection of antibodies to the human immunodeficiency virus in African sera.

H L Francis1, M Kabeya, N Kafuama, C Riggins, R Colebunders, R Ryder, J Curran, L Izaley, T C Quinn.   

Abstract

The sensitivities, specificities, and positive and negative predictive values of the Cambridge BioScience Corp. (Worcester, Mass.) human immunodeficiency virus latex agglutination assay were compared by using three different blood preparations. By using the manufacturer's standard test method with diluted sera, the sensitivity of latex agglutination was 100%, the specificity was 99.58%, and the positive and negative predictive values were 99.26 and 100%, respectively. Use of diluted whole blood or undiluted whole blood did not significantly affect the sensitivity (mean, 99.72%), specificity (mean, 99.47%), positive predictive value (mean, 99.07%), or negative predictive value (mean, 99.89%). The latex agglutination assay is a simple, rapid assay for the detection of human immunodeficiency virus that would be useful in Third World countries or other areas where enzyme-linked immunosorbent assays are not available or cannot be used.

Entities:  

Keywords:  Africa; Antibodies--analysis; Biology; Comparative Studies; Developing Countries; Diseases; Error Sources; Evaluation; Examinations And Diagnoses; False Negative Reactions; False Positive Reactions; Hemic System; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Measurement; Physiology; Research Methodology; Studies; Viral Diseases

Mesh:

Substances:

Year:  1988        PMID: 3235678      PMCID: PMC266920          DOI: 10.1128/jcm.26.11.2462-2464.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.

Authors:  J C Petricciani
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

2.  AIDS in Africa: an epidemiologic paradigm.

Authors:  T C Quinn; J M Mann; J W Curran; P Piot
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

3.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

4.  Detection of antibodies to human immunodeficiency virus by latex agglutination with recombinant antigen.

Authors:  C H Riggin; G A Beltz; C H Hung; R M Thorn; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus.

Authors:  J R Carlson; S C Mertens; J L Yee; M B Gardner; E J Watson-Williams; J Ghrayeb; M B Jennings; R J Biggar
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

6.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).

Authors:  R C Gallo; P S Sarin; E P Gelmann; M Robert-Guroff; E Richardson; V S Kalyanaraman; D Mann; G D Sidhu; R E Stahl; S Zolla-Pazner; J Leibowitch; M Popovic
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  HIV seroprevalence among hospital workers in Kinshasa, Zaire. Lack of association with occupational exposure.

Authors:  J M Mann; H Francis; T C Quinn; K Bila; P K Asila; N Bosenge; N Nzilambi; L Jansegers; P Piot; K Ruti
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

8.  Dot enzyme immunoassay. A simple, cheap and stable test for antibody to human immunodeficiency virus (HIV).

Authors:  J Ivo dos Santos; B Galvao-Castro; D C Mello; H G Pereira; M S Pereira
Journal:  J Immunol Methods       Date:  1987-05-20       Impact factor: 2.303

9.  Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV.

Authors:  T C Quinn; C H Riggin; R L Kline; H Francis; K Mulanga; M G Sension; A S Fauci
Journal:  JAMA       Date:  1988 Jul 22-29       Impact factor: 56.272

10.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

View more
  6 in total

1.  A rapid ultrasound particle agglutination method for HIV antibody detection: Comparison with conventional rapid HIV tests.

Authors:  Simon Bystryak; Natalya Ossina
Journal:  J Virol Methods       Date:  2017-08-24       Impact factor: 2.014

Review 2.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

3.  Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence.

Authors:  S Sirivichayakul; P Phanuphak; S Tanprasert; S Thanomchat; C Uneklabh; T Phutiprawan; C Mungklavirat; Y Panjurai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

4.  Evaluation of the Recombigen HIV-1 Latex Agglutination Test.

Authors:  C A Starkey; B Yen-Lieberman; M R Proffitt
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

5.  A pilot study to assess the performance of a rapid ultrasound particle agglutination method for the detection of HIV antibodies.

Authors:  Simon Bystryak; Rajiv P Bandwar; Natalya Ossina
Journal:  J Immunoassay Immunochem       Date:  2021-10-26

6.  Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India.

Authors:  Susmita Maity; Srijita Nandi; Subrata Biswas; Salil Kumar Sadhukhan; Malay Kumar Saha
Journal:  Virol J       Date:  2012-11-26       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.